Highlighted, GSEA analysis was employed to compare the differences between high- and low-risk groups, and the differences were majorly enriched in Cell Cycle, Oocyte Meiosis, Homologous Recombination, DNA Replication and P53 Signaling Pathways (Fig. 5, andTable S5), which were proved by plenty of works that significantly associated with tumor proliferation and drug resistance. The gene discussed is TP53; the disease is neoplasm.